Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 19, 1984 - Issue 3
Submit an article Journal homepage
5
Views
52
CrossRef citations to date
0
Altmetric
Original Articles

Safety of Ranitidine Maintenance Treatment of Duodenal Ulcer

E. J. S. BoydDept. of Therapeutics, University of Dundee, Dundee, Scotland
,
J. A. WilsonDept. of Therapeutics, University of Dundee, Dundee, Scotland
&
K. G. WormsleyDept. of Therapeutics, University of Dundee, Dundee, Scotland
Pages 394-400 | Received 05 Apr 1983, Accepted 01 Jul 1983, Published online: 30 Apr 2018

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

L. G. V. Coelho, M. C. F. Passos, Y. Chausson, E. L. Costa, A. F. Maia, M. J. C. C. Brandao, D. C. Rodrigues & L. P. Castro. (1992) Duodenal Ulcer and Eradication of Helicobacter pylori in a Developing Country An 18-Month Follow-up Study. Scandinavian Journal of Gastroenterology 27:5, pages 362-366.
Read now
. (1991) References. Scandinavian Journal of Gastroenterology 26:sup184, pages 22-27.
Read now
. (1990) References. Scandinavian Journal of Gastroenterology 25:sup177, pages 99-103.
Read now
E. J. S. Boyd, J. G. Penston & K. G. Wormsley. (1990) Maintenance Therapy of Duodenal and Gastric Ulcer with H2-Receptor Antagonists. Scandinavian Journal of Gastroenterology 25:sup178, pages 72-78.
Read now
F. I. Lee. (1990) High Doses of Ranitidine in Maintenance Therapy of Duodenal Ulcer Patients. Scandinavian Journal of Gastroenterology 25:sup178, pages 67-71.
Read now
E. Kaneko, S. Ooi, G. Ito & N. Honda. (1989) Natural History of Duodenal Ulcer Detected by the Gastric Mass Surveys in Men over 40 Years of Age. Scandinavian Journal of Gastroenterology 24:2, pages 165-170.
Read now
W. R. Murray, G. Cooper, G. Laferla, P. Rogers & M. Archibald. (1988) Maintenance Ranitidine Treatment after Haemorrhage from a Duodenal Ulcer: A 3-Year Study. Scandinavian Journal of Gastroenterology 23:2, pages 183-187.
Read now
. (1987) The Vote on the Motion. Scandinavian Journal of Gastroenterology 22:sup132, pages 46-46.
Read now
R. Jorde & P. G. Burhol. (1987) Asymptomatic Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 22:2, pages 129-134.
Read now
P. Bauerfeind, J. Popien, M. Traber, R. Bumm, M. Cucala, G. Dorta & A. L. Blum. (1986) Clinical Perspectives of Drugs Inhibiting Acid Secretion: Histamine H2 Antagonists. Scandinavian Journal of Gastroenterology 21:sup125, pages 42-49.
Read now
E. J. S. Boyd, J. A. Wilson & K. G. Wormsley. (1984) The Fate of Asymptomatic Recurrences of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 19:6, pages 808-812.
Read now

Articles from other publishers (41)

TSENG‐SHING CHEN, SHYH‐HAW TSAY, FULL‐YOUNG CHANG & SHOU‐DONG LEE. (2008) Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: Comparison of 1 week and 2 week regimens and recrudescence rates over 12 months . Journal of Gastroenterology and Hepatology 10:3, pages 300-305.
Crossref
T. G. Reilly & R. P. Walt. (1994) Duodenal ulcer treatment: progress from pH to HP. Journal of Clinical Pharmacy and Therapeutics 19:2, pages 73-80.
Crossref
Dennis M. Jensen, Susie Cheng, Thomas Kovacs, Gayle Randall, Mary Ellen Jensen, Terry Reedy, Harold Frankl, Gustavo Machicado, James Smith, Michael Silpa & Gary Van Deventer. (1994) A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal Ulcer. New England Journal of Medicine 330:6, pages 382-386.
Crossref
J. G. PENSTON. (2007) A decade of experience with long‐term continuous treatment of peptic ulcers with H 2 ‐receptor antagonists . Alimentary Pharmacology & Therapeutics 7:s2, pages 27-33.
Crossref
H. G. DAMMANN & T. A. WALTER. (2007) Efficacy of continuous therapy for peptic ulcer in controlled clinical trials. Alimentary Pharmacology & Therapeutics 7:s2, pages 17-25.
Crossref
D D Kerrigan, M E Taylor, N W Read & A G Johnson. (1993) Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.. Gut 34:8, pages 1042-1046.
Crossref
J. G. PENSTON, J. S. DIXON, E. J. S. BOYD & K. G. WORMSLEY. (2007) A placebo‐controlled investigation of duodenal ulcer recurrence after withdrawal of long‐term treatment with ranitidine. Alimentary Pharmacology & Therapeutics 7:3, pages 259-265.
Crossref
Robin Sloane & Hartley Cohen. (1993) COMMON-SENSE MANAGEMENT OF HELICOBACTER PYLORI–ASSOCIATED GASTRODUODENAL DISEASE. Gastroenterology Clinics of North America 22:1, pages 199-206.
Crossref
J. G. PENSTON & K. G. WORMSLEY. (2007) Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Alimentary Pharmacology & Therapeutics 6:5, pages 629-645.
Crossref
R. E. POUNDER, H. FESTEN & M. KORMAN. (2007) The long‐term management of duodenal ulceration using an H 2 ‐antagonist: symptomatic self‐care compared with maintenance treatment . Alimentary Pharmacology & Therapeutics 6:3, pages 315-325.
Crossref
J. G. PENSTON & K. G. WORMSLEY. (2007) Review article: maintenance treatment with H 2 ‐receptor antagonists for peptic ulcer disease . Alimentary Pharmacology & Therapeutics 6:1, pages 3-29.
Crossref
J. G. Penston, E. J. S. Boyd & K. G. Wormsley. (1992) Complications associated with ulcer recurrence following gastric surgery for ulcer disease. Gastroenterologia Japonica 27:1, pages 129-141.
Crossref
James V. Egan & Dennis M. Jensen. (1991) Long-term Management of Patients with Bleeding Ulcers: Rationale, Results, and Economic Impact. Gastrointestinal Endoscopy Clinics of North America 1:2, pages 367-385.
Crossref
Julio Garcia-Paredes, M. Diaz Rubio, Felix Llenas, C. Taxonera & L. Pardo. (1991) Comparison of sucralfate and ranitidine in the treatment of duodenal ulcers. The American Journal of Medicine 91:2, pages S64-S67.
Crossref
B. Pym, K. Byth & D.W. Piper. (1991) Reply. Gastroenterology 100:5, pages 1486-1487.
Crossref
J. H. LEWIS. (2007) Safety profile of long‐term H 2 ‐antagonist therapy . Alimentary Pharmacology & Therapeutics 5:s1, pages 49-57.
Crossref
J. H. Lewis. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease 263 300 .
J. G. PENSTON & K. G. WORMSLEY. (2007) Review article: asymptomatic duodenal ulcers—implications of heterogeneity. Alimentary Pharmacology & Therapeutics 4:6, pages 557-567.
Crossref
Jeffrey S. Flier, Lisa H. Underhill & Andrew H. Soll. (1990) Pathogenesis of Peptic Ulcer and Implications for Therapy. New England Journal of Medicine 322:13, pages 909-916.
Crossref
James W. Freston. (1990) Overview of Medical Therapy of Peptic Ulcer Disease. Gastroenterology Clinics of North America 19:1, pages 121-140.
Crossref
C. W. Howden. (1988) Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.. BMJ 297:6660, pages 1393-1394.
Crossref
K. G. Wormsley. (1988) Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: reduces morbidity in a significant minority of patients.. BMJ 297:6660, pages 1392-1394.
Crossref
K. D. BARDHAN. (2007) Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Alimentary Pharmacology & Therapeutics 2:5, pages 395-405.
Crossref
Janet D. Elashoff, Gary G. Koch & George Y. H. Chi. (2006) Designing a clinical trial to demonstrate prevention of ulcer recurrence: Modelling simulation approaches. Statistics in Medicine 7:8, pages 877-888.
Crossref
E.J.S. Boyd, D.A. Johnston, J.G. Penston & K.G. Wormsley. (1988) DOES MAINTENANCE THERAPY KEEP DUODENAL ULCERS HEALED?. The Lancet 331:8598, pages 1324-1327.
Crossref
W. Schepp & M. Classen. 1988. Der Internist. Der Internist 734 744 .
Miguel Rodrigo, Jaoquin Berenguer, Joaquin Hinojosa, Jose M. Balanzo & Jose L. Segu. (1987) Sucralfate and cimetidine as maintenance treatment in the prevention of duodenal ulcer recurrence. The American Journal of Medicine 83:3, pages 99-104.
Crossref
Rosemary R. BerardiMaureen E. SavitskyTimothy T. Nostrant. (2017) Maintenance Therapy for Prevention of Recurrent Peptic Ulcers. Drug Intelligence & Clinical Pharmacy 21:6, pages 493-501.
Crossref
R Jorde, P G Burhol & T Hansen. (1987) Ranitidine 150 mg at night in the prevention of gastric ulcer relapse.. Gut 28:4, pages 460-463.
Crossref
E. J. S. BOYD, D. A. JOHNSTON, K. G. WORMSLEY, W. N. JENNER & X. SALANSON. (2007) The effects of cigarette smoking on plasma concentrations of gastric antisecretory drugs. Alimentary Pharmacology & Therapeutics 1:1, pages 57-65.
Crossref
H.R. Koelz, R. Birchler, A. Bretholz, B. Bron, Y. Capitaine, G. Delmore, H.F. Fehr, I. Fumagalli, J. Gehrig, J.J. Gonvers, F. Halter, B. Hammer, L. Kayasseh, E. Kobler, G. Miller, G. Münst, S. Pelloni, S. Realini, P. Schmid, M. Voirol & A.L. Blum. (1986) Healing and Relapse of Reflux Esophagitis During Treatment With Ranitidine. Gastroenterology 91:5, pages 1198-1205.
Crossref
Dennis M. Jensen. (1986) Economic and health aspects of peptic ulcer disease and H2-receptor antagonists. The American Journal of Medicine 81:4, pages 42-48.
Crossref
E.Clinton TexterJr.Jr., Farhad Navab, Geraldine Mantell & Rayanne Berman. (1986) Maintenance therapy of duodenal ulcer with famotidine: A multicenter United States study. The American Journal of Medicine 81:4, pages 25-32.
Crossref
JA Wilson, DA Johnston, J. Penston & KG Wormsley. (2012) Inhibition of human gastric secretion by ICI 162,846‐a new histamine H2‐receptor antagonist.. British Journal of Clinical Pharmacology 21:6, pages 685-689.
Crossref
J.Paul Miller. (1986) Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy. Gastroenterology 90:6, pages 2040-2041.
Crossref
K D Bardhan, R F C Hinchliffe & K Bose. (1986) Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. Postgraduate Medical Journal 62:727, pages 347-351.
Crossref
P. Hogston. (1985) Antihypertensive treatment in pregnancy. BMJ 291:6500, pages 968-969.
Crossref
R M Watkins & J. Collin. (1985) Deaths from peptic ulceration. BMJ 291:6500, pages 968-968.
Crossref
K G Wormsley. (1985) Deaths from peptic ulceration. BMJ 291:6500, pages 968-968.
Crossref
S Shuster. (1985) Over the counter sale of topical corticosteroids.. BMJ 291:6500, pages 967-968.
Crossref
Gabriel L. Garay & Joseph M. Muchowski. 1985. 93 105 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.